Related references
Note: Only part of the references are listed.Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
Issaka Sagara et al.
LANCET (2018)
Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2018)
Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum
Selina Bopp et al.
NATURE COMMUNICATIONS (2018)
Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine
Leila S. Ross et al.
NATURE COMMUNICATIONS (2018)
Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
Juliana Inoue et al.
EMERGING INFECTIOUS DISEASES (2018)
Drug-Resistant Polymorphisms and Copy Numbers in Plasmodium falciparum, Mozambique, 2015
Himanshu Gupta et al.
EMERGING INFECTIOUS DISEASES (2018)
Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia
Christian M. Parobek et al.
GENOME BIOLOGY AND EVOLUTION (2017)
Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity
Sonia Agrawal et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2017)
Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study
Roberto Amato et al.
LANCET INFECTIOUS DISEASES (2017)
Emergence of Plasmodium falciparum triple mutant in Cambodia
Gabriele Rossi et al.
LANCET INFECTIOUS DISEASES (2017)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2017)
Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2017)
Rapid decline in the susceptibility of Plasmodium falciparum to dihydroartemisinin-piperaquine in the south of Vietnam
Ngo Viet Thanh et al.
MALARIA JOURNAL (2017)
Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic
Benjamin Blasco et al.
NATURE MEDICINE (2017)
A Variant PfCRT Isoform Can Contribute to Plasmodium falciparum Resistance to the First-Line Partner Drug Piperaquine
Satish K. Dhingra et al.
MBIO (2017)
Plasmodium falciparum K13 Mutations Differentially Impact Ozonide Susceptibility and Parasite Fitness In Vitro
Judith Straimer et al.
MBIO (2017)
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Didier Menard et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread
Charles J. Woodrow et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Changing Antimalarial Drug Sensitivities in Uganda
Stephanie A. Rasmussen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria
Fiona Macintyre et al.
BMC MEDICINE (2017)
Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
Bui Quang Phuc et al.
EMERGING INFECTIOUS DISEASES (2017)
Population Structure Shapes Copy Number Variation in Malaria Parasites
Ian H. Cheeseman et al.
MOLECULAR BIOLOGY AND EVOLUTION (2016)
Artefenomel: a promising new antimalarial drug
Philip J. Rosenthal
LANCET INFECTIOUS DISEASES (2016)
Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study
Chanaki Amaratunga et al.
LANCET INFECTIOUS DISEASES (2016)
A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms
D. Menard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic epidemiology of artemisinin resistant malaria
Roberto Amato et al.
ELIFE (2016)
Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment
Rithea Leang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Plasmodium falciparum dihydroartemisinin-piperaquine failures in Cambodia are associated with mutant K13 parasites presenting high survival rates in novel piperaquine in vitro assays: retrospective and prospective investigations
Valentine Duru et al.
BMC MEDICINE (2015)
Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola
Kinanga Kiaco et al.
MALARIA JOURNAL (2015)
Analysis of Major Genome Loci Underlying Artemisinin Resistance and pfmdr1 Copy Number in pre- and post-ACTs in Western Kenya
Bidii S. Ngalah et al.
SCIENTIFIC REPORTS (2015)
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P-falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
Meera Venkatesan et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
Dihydroartemisinin-Piperaquine Failure in Cambodia
David L. Saunders et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2013)
An innovative tool for moving malaria PCR detection of parasite reservoir into the field
Lydie Canier et al.
MALARIA JOURNAL (2013)
Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives
Jennifer A. Flegg et al.
MALARIA JOURNAL (2013)
Increased pfmdr1 gene copy number and the decline in pfcrt and pfmdr1 resistance alleles in Ghanaian Plasmodium falciparum isolates after the change of anti-malarial drug treatment policy
Nancy O. Duah et al.
MALARIA JOURNAL (2013)
Increased pfmdr1 Copy Number and Sequence Polymorphisms in Plasmodium falciparum Isolates from Sudanese Malaria Patients Treated with Artemether-Lumefantrine
Nahla B. Gadalla et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Multiple Genetic Backgrounds of the Amplified Plasmodium falciparum Multidrug Resistance (pfmdr1) Gene and Selective Sweep of 184F Mutation in Cambodia
Sumiti Vinayak et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Spread and evolution of Plasmodium falciparum drug resistance
Toshihiro Mita et al.
PARASITOLOGY INTERNATIONAL (2009)
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria
RN Price et al.
CLINICAL INFECTIOUS DISEASES (2006)
Share Paper
